Literature DB >> 1416833

Antimicrobial susceptibilities of a Corynebacterium CDC group I1 strain isolated from a patient with endocarditis.

G J Malanoski1, R Parker, G M Eliopoulos.   

Abstract

We encountered a case of native valve endocarditis due to Corynebacterium CDC group I1 which was successfully controlled with antimicrobial agents alone. This organism and three other isolates of this group were susceptible to penicillin, vancomycin, and gentamicin. The combination of penicillin with subinhibitory concentrations of gentamicin resulted in a 1,000-fold decrease in CFU per milliliter at 24 h compared with penicillin alone. Augmentation of killing was noted also with vancomycin plus gentamicin but to a degree that did not meet strict criteria for bactericidal synergism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416833      PMCID: PMC190341          DOI: 10.1128/AAC.36.6.1329

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Corynebacterium pyogenes endocarditis. Report of a case with necropsy and review of the literature.

Authors:  P Jootar; V Gherunpong; K Saitanu
Journal:  J Med Assoc Thai       Date:  1978-10

2.  Endocarditis due to Corynebacterium CDC group G2.

Authors:  G E Austin; E O Hill
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

3.  Diphtheroid prosthetic valve endocarditis. A study of clinical features and infecting organisms.

Authors:  B E Murray; A W Karchmer; R C Moellering
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

4.  Postoperative prosthetic valve bacterial endocarditis due to Corynebacterium xerosis.

Authors:  J E Geraci; R J Forth; F H Ellis
Journal:  Mayo Clin Proc       Date:  1967-11       Impact factor: 7.616

5.  Diphtheroid endocarditis. Report of nine cases and review of the literature.

Authors:  J L Gerry; W B Greenough
Journal:  Johns Hopkins Med J       Date:  1976-08

6.  Prosthetic valve endocarditis.

Authors:  W R Wilson; G K Danielson; E R Giuliani; J E Geraci
Journal:  Mayo Clin Proc       Date:  1982-03       Impact factor: 7.616

7.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

8.  Corynebacterium xerosis endocarditis.

Authors:  R Eliakim; P Silkoff; G Lugassy; J Michel
Journal:  Arch Intern Med       Date:  1983-10

Review 9.  Infections caused by nondiphtheria corynebacteria.

Authors:  B A Lipsky; A C Goldberger; L S Tompkins; J J Plorde
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

10.  Corynebacterium bovis as a cause of human disease.

Authors:  J A Vale; G W Scott
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

View more
  3 in total

Review 1.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Prosthetic valve endocarditis caused by Corynebacterium afermentans subsp. lipophilum (CDC coryneform group ANF-1).

Authors:  D L Sewell; M B Coyle; G Funke
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

3.  Corynebacterium endocarditis species-specific risk factors and outcomes.

Authors:  Jaime Belmares; Stephanie Detterline; Janet B Pak; Jorge P Parada
Journal:  BMC Infect Dis       Date:  2007-02-06       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.